Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
ZNTL

Updated 10/6/2026, 2:28 PM ET.

ZNTL

Zentalis Pharmaceuticals, Inc.

Buy$15,172,500

WALTERS GROUP

10% owner

and 2 others

4,335,000 shat $3.50Filed Aug 19, 6:11 PM ETFiling

Read from public SEC filings. Not financial advice.